Pharm Exec sat down with Mike Gladstone, Pfizer’s Global President of Inflammation & Immunology (I&I), to discuss how Pfizer is addressing the unmet need in I&I,
Accelerating Gender Parity and Diversity
The Gender Parity Collaborative is an award-winning consortium of healthcare and life-sciences companies dedicated to accelerating gender parity and diversity. Together, our Collaborative members commit to taking an active role in defining strategies, measuring performance, creating change and inspiring others.
By taking bold action to close the gender gap, the healthcare and life-sciences industry can achieve more.
During the past few decades, gender parity has been of increasing priority for most companies around the world. Research shows that greater gender balance drives better business results, more innovation and high employee retention. For the past 40 plus years, the HBA has been relentlessly working alongside prominent organizations to further the advancement and impact of women in the business of healthcare. Our sector has made great strides towards a more gender diverse workplace, but the pace of change is still too slow. We can do much better. Faster.
The Gender Parity Collaborative (“the Collaborative”) is bringing together senior executives from various industry organizations to discuss the necessary environmental and systemic changes needed to accelerate the pace of change — and transforming our industry in the process.